Fibromyalgia — all decisions

The Board denied the Veteran's claim for a rating in excess of 40 percent for fibromyalgia with unexplained fatigue, as the disability does not result in symptomatology that is not contemplated by the currently assigned rating.

The Board denied the veteran's claims for increased ratings and service connection, finding that the evidence did not support higher ratings or service connection.

The Board denied the veteran's claims for increased ratings and service connection, finding no evidence to support a diagnosis or onset of the claimed conditions during active duty.

The Board granted restoration of the 20 percent rating for degenerative arthritis of the spine, effective September 28, 2020, and granted service connection for fibromyalgia. The other claims were either denied or remanded.

The Board granted service connection for tinnitus, chronic sinusitis, and a 50% disability rating for migraine headaches effective June 12, 2019. Other claims were remanded.

The Board granted service connection for a back disability and a left shoulder disability, but denied increased ratings for PTSD and TMD, as well as service connections for chronic sinusitis, respiratory insufficiency, dyspnea, CFS, fibromyalgia, dermatitis, functional abdominal pain syndrome, bloating, hypogonadism, hypothyroidism, IBS, and sleep apnea.

The Board denied the veteran's appeal for earlier effective dates for service connection of multiple conditions, including multiple myeloma, schizotypal personality disorder with mild neurocognitive disorder, fibromyalgia, vitamin D deficiency, migraine headaches, and others.

The Board granted restoration of a 70 percent rating for PTSD from March 1, 2021, and an evaluation of 30 percent effective April 21, 2006, and 50 percent effective January 15, 2015, for migraines.

The Board dismissed several appeals for higher disability ratings and effective dates, but remanded issues related to fibromyalgia, irritable bowel syndrome, and psychiatric disability.

The Board remands the Veteran's claims for additional development, specifically to obtain an adequate VA medical opinion that addresses the etiology of the Veteran's claimed conditions, with consideration and discussion of relevant evidence.

The Veteran withdrew the appeal for all service connection and increased rating claims, effective March 14, 2025.

The Veteran's fibromyalgia is granted a rating of 40 percent, the maximum schedular rating, as his symptoms are constant or nearly so and refractory to therapy.

The Board denied service connection for fibromyalgia, CFS, stomach condition, and skin condition as there was no current diagnosis. The claims for left hip, right hip, neck conditions, and dental treatment purposes were remanded.

The Veteran withdrew his appeal for service connection for chronic fatigue syndrome, fibromyalgia, an acquired psychiatric disability including depression, and right knee pain.

The Board granted service connection for fibromyalgia, finding the evidence to be in equipoise that it was incurred during active service.

The Board denied referral for an extraschedular rating and special monthly compensation for the Veteran's fibromyalgia and back disability, as well as aid and attendance or housebound status.

The Board granted service connection for fibromyalgia and radiculopathy of the right lower extremity, while remanding claims for tinnitus and an increased rating for chronic back pain with degenerative arthritis.

The Board granted a 60 percent rating for chronic fatigue syndrome (CFS) but denied increased ratings for fibromyalgia and irritable bowel syndrome (IBS).

The Board denied service connection for bilateral hearing loss, bilateral tinnitus, and fibromyalgia as the evidence did not show a current disability according to VA standards or a nexus between the claimed conditions and the Veteran's active duty.

The Board granted a 30 percent rating for irritable bowel syndrome (IBS) and a 40 percent rating for fibromyalgia, but denied service connection for hypertension, diverticulitis, and GERD.